Hunan Xinghui Medical Investment Management Co., Ltd. signed an agreement to acquire 10.1% stake in NanHua Bio-medicine Co., Ltd. (SZSE:000504) from Shanghai Heping Large Equity Investment Fund Management Limited for approximately CNY 690 million on June 8, 2018. Under the terms of transaction, Hunan Xinghui Medical Investment Management Co., Ltd. acquired 31.5 million shares for CNY 691.4 million. The first installment of CNY 207.4 million will be paid within 3 days since the signing of agreement and a second installment of CNY 483.9 million will be paid before December 31, 2018. As of June 6, 2019, Shenzhen Linze Investment Co., Ltd. and Shanghai Heping Large Equity Investment Fund Management Limited decided to postpone the payment of the balance of until September 30, 2019. Hunan Xinghui Medical Investment Management Co., Ltd. cancelled the acquisition of 10.1% stake in NanHua Bio-medicine Co., Ltd. (SZSE:000504) from Shanghai Heping Large Equity Investment Fund Management Limited on December 10, 2019.